MLchartDataset catalogue

Vizimpro

Term · Oncology and biomedicine · MLC-T-ONC-009299

A drug used to treat non-small cell lung cancer that has spread, has not already been treated, and has certain mutations (changes) in the EGFR gene. It is also being studied in the treatment of other types of cancer. Vizimpro blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called dacomitinib and PF-00299804.

Table 1. Record
IdentifierMLC-T-ONC-009299
FieldOncology and biomedicine
Synonymsdacomitinib; PF-00299804
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009299",
  "term": "Vizimpro",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat non-small cell lung cancer that has spread, has not already been treated, and has certain mutations (changes) in the EGFR gene. It is also being studied in the treatment of other types of cancer. Vizimpro blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called dacomitinib and PF-00299804.",
  "synonyms": [
    "dacomitinib",
    "PF-00299804"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/vizimpro/"
}

Record 17,310 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.